x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Oncology Podcast

Decera Clinical Education

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:19:44

Call to Action and Reflection: Inclusive,...

Decera Clinical Education Oncology Podcast ·

2022/05/13

In this episode for all healthcare professionals and any patient-facing clinical staff, Nelson F. Sanchez, MD, shares key insights on the need for equitable, compassionate healthcare for transgender individuals, along with practical guidance based on his clinical experience caring for these patients. Topics include:Communication and physical exam skillsSpecific clinical care needs of transgender individuals related to transitionCreating an inclusive and welcoming environment for transgender patients

en

00:16:43

Inclusive Healthcare for Transgender Individuals:...

Decera Clinical Education Oncology Podcast ·

2022/05/02

In this episode, Pharmacist Olivia Buckoski shares her experience undergoing medical and social transition and offers advice from the perspective of both a transgender person and healthcare professional on caring for transgender individuals. Topics include:Importance of educating entire care team about needs of transgender individuals, starting with the waiting roomSpecific advice for the exam roomPharmacy and adherence considerations with hormone therapyExamples of uninformed care

en

00:22:02

Anti-TIGIT Therapy: Overview of Current Clinical...

Decera Clinical Education Oncology Podcast ·

2022/04/15

In this episode, Jyoti D. Patel, MD, and Ani Balmanoukian, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune checkpoint target with promising results in PD-L1-positive NSCLC. The episode includes a review of phase II data on the use of tiragolumab plus atezolizumab in NSCLC, the use of PD-L1 as a marker of response, the potential role of anti-TIGIT therapies in solid tumors, and ongoing trials in lung cancer including SKYSCRAPER-01, SKYSCRAPER-02, SKYSCRAPER-03,

en

00:20:40

Targeting TIGIT: Understanding New Approaches for...

Decera Clinical Education Oncology Podcast ·

2022/04/07

In this episode, Jyoti D. Patel, MD, and Diwakar Davar, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune checkpoint target with promising early-phase clinical trial results. The episode includes a comprehensive explanation of TIGIT, how the TIGIT pathway functions, and the potential role of TIGIT inhibition for the treatment of cancer, including analyses from ongoing clinical trials such as CITYSCAPE, PACIFIC-8, ARC-7, and SKYSCRAPER-01.Presenters:Jyoti D. Patel,

en

00:21:24

Evolving Treatment Landscape With Regorafenib and...

Decera Clinical Education Oncology Podcast ·

2022/04/06

In this episode, Nilofer S. Azad, MD, and Kanwal Raghav, MD, discuss current and emerging uses of regorafenib and TAS-102 in later-line treatment of patients with mCRC, with topics including:Current use of regorafenib and TAS-102 monotherapyCombination therapy with regorafenib and PD-1 inhibitorsAdding bevacizumab to TAS-102Presenters:Nilofer S. Azad, MD Professor, Oncology Sidney Kimmel Comprehensive Cancer Center Johns Hopkins UniversityBaltimore, Maryland Kanwal Raghav, MDAssociate Professor,

en

00:28:04

Expert Answers to Key Questions on Current and...

Decera Clinical Education Oncology Podcast ·

2022/03/31

In this episode, Jeff P. Sharman, MD; Matthew S. Davids, MD, MMSc; and Anthony Mato, MD, MSCE, answer questions from a live CCO webinar on current best practices and emerging strategies in BTK inhibitor therapy for patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), with questions including:For patients with CLL, when should acalabrutinib-, ibrutinib-, or venetoclax-based regimens be considered?What is the optimal therapy for a patient with del(17p) CLL?When should an

en

00:34:01

Expert Insights on Optimal Current Management of...

Decera Clinical Education Oncology Podcast ·

2022/03/21

In this episode, Lipika Goyal, MD, leads an engaging discussion with Christine Chio, PharmD, BCOP, and Caroline Kuhlman, NP, on current treatment of patients with cholangiocarcinoma. Topics include:Initial diagnosisBiomarker testing to guide treatment with immunotherapies and targeted agentsAdverse event managementStrategies for counseling patientsPresenters:Christine Chio, PharmD, BCOPClinical Ambulatory GI Oncology PharmacistDepartment of PharmacyMassachusetts General HospitalBoston,

en

00:28:06

Cancer Conversations: 3 Case Challenges of Real...

Decera Clinical Education Oncology Podcast ·

2022/03/14

In this podcast episode, Amy DeZern, MD, MHS, Daniel Pollyea, MD, MS, and Amer Zeidan, MBBS, discuss challenging cases in MDS, includingTreatment for MDS after ESA failureStrategies for patients with intermediate- or high-risk MDSLuspatercept therapy in MDSMDS case challengesLink to full program, including downloadable slidesets:https://bit.ly/3tYwcYuPresenters: Amy E. DeZern, MD, MHSAssociate ProfessorOncology and MedicineThe Johns Hopkins University School of MedicineBaltimore, MarylandDaniel

en

00:39:33

Expert Insights on Targeted Therapies for Advanced...

Decera Clinical Education Oncology Podcast ·

2022/03/10

In this episode, Dr Prithviraj Bose, Pharmacist Caitlin R. Rausch, and Nurse Practitioner Ilene A. Galinsky discuss incorporating KIT-targeted therapies into management of patients with advanced systemic mastocytosis. Topics include:Diagnosis and prognosis of advanced systemic mastocytosisClinical trial data on efficacy of avapritinib and midostaurinMonitoring for and managing key toxicities with avapritinib, including cognitive dysfunctionPresenters:Prithviraj Bose, MDAssociate ProfessorDivision of

en

00:30:57

Advances in B-Cell Lymphomas: Understanding Current...

Decera Clinical Education Oncology Podcast ·

2022/02/25

In this episode, Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, discuss treatment approaches for patients with B-cell lymphomas, including information on: Follicular lymphomaMarginal zone lymphomaMantle cell lymphomaDiffuse large B-cell lymphomaPosttransplant lymphoproliferative disorderPresenters:Julie M. Vose, MD, MBAChief, Division of Oncology and HematologyNeumann M. and Mildred E. Harris ProfessorDepartment of Internal MedicineUniversity of Nebraska Medical CenterOmaha,

en

00:17:14

TKIs for Advanced HCC in the Second Line and Beyond

Decera Clinical Education Oncology Podcast ·

2022/02/22

In this podcast episode from Clinical Care Options (CCO), Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss second line treatment of patients with advanced hepatocellular carcinoma. Topics include:Available agents for the management of advanced hepatocellular carcinoma in the second lineThe current role of tyrosine kinase inhibitors in second-line treatment of advanced hepatocellular carcinomaOngoing clinical trials in the second-line settingPresenters: Josep M. Llovet, MD,

en

00:18:47

New Directions With PARP Inhibitors in Pancreatic Cancer

Decera Clinical Education Oncology Podcast ·

2022/02/21

In this episode, Eileen M. O’Reilly, MD, and Naureen Starling, MD, FRCP, discuss emerging therapeutic strategies involving PARP inhibitor therapy in the treatment of pancreatic cancer. Topics include:Current treatment landscape and testing in the United States vs the United Kingdom Testing for molecular subgroups beyond BRCAmUsing PARP inhibitors in earlier stages of the diseaseLearning from other cancers, such as prostate, breast, and ovarian Presenters:Eileen M. O’Reilly, MDWinthrop Rockefeller

en

00:43:05

Evolving Therapy for Myeloma: Experts Discuss Patient...

Decera Clinical Education Oncology Podcast ·

2022/02/18

In this episode,Brian G.M. Durie, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD; and Jesús F. San-Miguel, MD, PhD, discuss treatment approaches for multiple myeloma using example patient cases.Smoldering myelomaInduction therapy for autologous stem cell transplant–eligible patientsFirst-line approaches for autologous stem cell transplant–ineligible patientsTreatment after first relapseSelecting therapy for heavily pretreated myelomaPresenters:Brian G.M. Durie, MDMedical

en

00:23:46

Expert Insights on Advances in Immune Thrombocytopenia

Decera Clinical Education Oncology Podcast ·

2022/02/07

In this episode, Keith R. McCrae, MD; Nichola Cooper, MD; and Rachael Grace, MD, MMSc,provide expert insights on immune thrombocytopenia management, along with addressing frequently asked questions from a live CCO symposium. Topics include:New and emerging therapeutic optionsSpecial patient populations, including childrenThe management of immune thrombocytopeniaCOVID-19 vaccinations and immune thrombocytopeniaPresenters:Keith R. McCrae, MDProfessor of Molecular MedicineDepartment of Hematology and

en

00:19:59

Precision Medicine for aTTP: Expert Answers to Your...

Decera Clinical Education Oncology Podcast ·

2022/02/01

In this episode, Ara Metjian, MD; Paul Coppo, MD, PhD; and Marshal Mazepa, MD, answer questions from an audience of healthcare professionals on topics related to the management of acquired thrombotic thrombocytopenic purpura (aTTP), including: Rationale of the CAPLAVIE regimen of caplacizumab with corticosteroids and rituximab in aTTP in the acute phaseData for caplacizumab in pediatric patients with aTTPInitiating rituximab after completion of plasma exchangeInternational Society on Thrombosis and

en

00:17:09

Precision Medicine for T-Cell Lymphomas: Expert...

Decera Clinical Education Oncology Podcast ·

2022/01/31

In this episode, Steven M. Horwitz, MD; Francine Foss, MD; and Barbara Pro, MD, answer questions from an audience of healthcare professionals on topics related to the management of patients with T-cell lymphomas including:Threshold of CD30 positivity useful to inform brentuximab vedotin use in patients with CTCL and PTCLManaging relapsed mycosis fungoides after allogeneic SCTExperience with ALK inhibition in ALCL with central nervous system metastasesManaging refractory pruritus in CTCLRole of PI3K

en

00:28:12

Multidisciplinary Overview of EGFR-Mutated NSCLC: An...

Decera Clinical Education Oncology Podcast ·

2022/01/26

In this podcast episode, Conor Ernst Steuer, MD, a medical oncologist; Frank Schneider, MD, a pathologist; and Elise Hitron, MSN, FNP-C, a phase I clinical trials nurse practitioner, engage in a multidisciplinary discussion of the latest management strategies for EGFR-mutated NSCLC. Topics include:Testing for targetable biomarkersTalking with patients about biomarker testingFrontline therapy for EGFR-positive NSCLCResistance to front-line osimertinibTreatment of EGFR TKI–resistant disease, including

en

00:12:57

Experts Answer Questions on Current and Emerging...

Decera Clinical Education Oncology Podcast ·

2022/01/14

In this podcast episode, 3 experts answers questions on the management of hemophilia A from a live webinar. Topics include: Which patients should have pharmacokinetic-guided therapy?Toxicities with PEGylated extended half-life productsFactor VIII and bone healthFactor VIII peaks, thrombotic risk, and cardiovascular diseaseChoosing between extended half-life products and emicizumab for active patientsRole of fitusiran in the treatment paradigm if approvedPresenters:Miguel A. Escobar, MDProfessor of

en

00:14:37

Induction and Maintenance Therapy for Fit Patients...

Decera Clinical Education Oncology Podcast ·

2022/01/10

In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:Induction chemotherapy and consolidation therapyUse of gemtuzumab ozogamicinManagement of sinusoidal obstruction syndrome Nursing considerations for younger, fit patients with AMLPresenter:Ashley Leak Bryant, PhD, RN, OCN, FAANAssociate ProfessorSchool of NursingUNC Lineberger Comprehensive Cancer Center University of North

en

00:18:07

Targeted Treatment Options for Patients With AML and...

Decera Clinical Education Oncology Podcast ·

2022/01/10

In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses targeted therapy with FLT3 and IDH1/2 inhibitors in AML, with a focus on the nursing perspective. Topics include:Approved and emerging treatment options for FLT3-mutated AMLManagement of adverse events associated with FLT3 inhibitorsTherapies for IDH1- and IDH2-mutated AMLIdentifying and managing differentiation syndrome associated with IDH1/2 inhibitorsPresenters:Sarah M. Tinsley, PhD, APRN, AOCNNurse PractitionerCourtesy

en

224 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College